Free Trial

Federated Hermes Inc. Increases Holdings in Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background
Remove Ads

Federated Hermes Inc. raised its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 65.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 762,189 shares of the company's stock after acquiring an additional 302,786 shares during the period. Federated Hermes Inc. owned about 1.67% of Azenta worth $38,109,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Picton Mahoney Asset Management lifted its holdings in shares of Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after purchasing an additional 532 shares during the period. Headlands Technologies LLC bought a new position in Azenta during the 4th quarter worth $40,000. KBC Group NV lifted its stake in shares of Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after acquiring an additional 698 shares during the period. Assenagon Asset Management S.A. bought a new stake in shares of Azenta in the 4th quarter valued at $200,000. Finally, Landscape Capital Management L.L.C. acquired a new stake in Azenta during the 4th quarter worth about $217,000. Institutional investors and hedge funds own 99.08% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on AZTA shares. TD Cowen raised Azenta to a "hold" rating in a research note on Thursday, February 27th. Evercore ISI boosted their target price on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research report on Thursday, February 6th. Needham & Company LLC raised their price target on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. Finally, Stephens reaffirmed an "overweight" rating and set a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd.

Remove Ads

View Our Latest Report on Azenta

Azenta Stock Up 0.7 %

NASDAQ AZTA traded up $0.18 on Friday, reaching $26.71. The company had a trading volume of 1,111,613 shares, compared to its average volume of 631,643. The stock has a market capitalization of $1.22 billion, a P/E ratio of -8.96 and a beta of 1.66. The company's fifty day moving average is $39.42 and its 200 day moving average is $44.72. Azenta, Inc. has a 52-week low of $25.36 and a 52-week high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, research analysts expect that Azenta, Inc. will post 0.53 EPS for the current year.

About Azenta

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

See Also

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads